Basis: (FMP quote price / unrounded diluted TTM EPS) / explicitly dated EPS growth percent. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-09-12T00:15:35.677Z.
Calculation as of: 2026-09-12T00:15:35.677Z.
Quote observation: 2026-09-11T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ddd63485a43e27ae5d23ef79ae4ae0a88e1f84f529dfa76bd2161c08446e3651
PEG RATIO
N/A
Humana Inc.
Market Cap
$49.21B
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Humana Inc. (HUM) | $49.21B | N/A |
| Becton, Dickinson and Company (BDX)vs › | $49.00B | N/A |
| Edwards Lifesciences Corporation (EW)vs › | $48.58B | N/A |
| Cardinal Health, Inc. (CAH)vs › | $54.94B | N/A |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $43.20B | N/A |
| IQVIA Holdings Inc. (IQV)vs › | $43.09B | N/A |
| Agilent Technologies, Inc. (A)vs › | $41.50B | N/A |
| Moderna, Inc. (MRNA)vs › | $57.13B | N/A |
| IDEXX Laboratories, Inc. (IDXX)vs › | $39.81B | N/A |
| Cencora, Inc. (COR)vs › | $62.57B | N/A |
PEG Ratio
N/A
P/E Ratio
38.8
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute